Gaxos.ai's portfolio company AFD deploys Anduril Lattice Platform to enhance anti-drone defense systems, marking a milestone in AI-powered security solutions. TheGaxos.ai's portfolio company AFD deploys Anduril Lattice Platform to enhance anti-drone defense systems, marking a milestone in AI-powered security solutions. The

Gaxos.ai Portfolio Company Deploys Anduril Lattice Platform for Enhanced Anti-Drone Defense

2026/03/24 21:25
2 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

Gaxos.ai Inc. (NASDAQ: GXAI) announced that its portfolio company, America First Defense (AFD), has begun deployment of the Anduril Lattice Platform to expand its counter-swarm UAV and anti-drone defense systems. This integration represents a key milestone in advancing AFD’s autonomous defense infrastructure, enhancing its ability to identify, track, assess and respond to evolving unmanned aerial threats.

The deployment supports AFD’s focus on layered, AI-enabled counter-UAS solutions as demand grows for adaptive, software-defined defense technologies. The Anduril Lattice Platform integration provides AFD with enhanced capabilities to address the increasing sophistication of drone threats across various operational environments.

Gaxos.ai is a technology company focused on reshaping how people interact with artificial intelligence across everyday life and high-impact industries. The company is building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The latest news and updates relating to GXAI are available in the company’s newsroom at https://ibn.fm/GXAI.

The growing portfolio of Gaxos.ai spans defense, health and wellness, entertainment, and productivity sectors, bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. This defense sector advancement through AFD represents one component of the company’s broader strategy to deploy AI solutions across multiple industries.

The announcement was distributed through BioMedWire, a specialized communications platform with a focus on the latest developments in the Biotechnology, Biomedical Sciences and Life Sciences sectors. BioMedWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN that delivers access to wire solutions, article syndication, press release enhancement, social media distribution and corporate communications solutions. More information about BioMedWire is available at https://www.BioMedWire.com.

This deployment comes at a time when defense technologies are increasingly incorporating artificial intelligence and autonomous systems to address emerging security challenges. The integration of the Anduril Lattice Platform into AFD’s defense systems represents a practical application of AI technology in the defense sector, aligning with broader industry trends toward more adaptive and responsive security solutions.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Gaxos.ai Portfolio Company Deploys Anduril Lattice Platform for Enhanced Anti-Drone Defense.

The post Gaxos.ai Portfolio Company Deploys Anduril Lattice Platform for Enhanced Anti-Drone Defense appeared first on citybuzz.

Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.